Pharma Sessions
Navigating pharmaceutical launch excellence through strategy, technology and career stories. (And sharing fun moments too!)
Episodes
26 episodes
Bursting the Med Affairs Bubble with Dr. Samin Saeed, VP Early Medical Pipeline at GSK
Bursting the Medical Affairs Bubble: A Conversation on Cross-Functional CollaborationIn this episode of Pharma Sessions, host Jonathan Kaskey talks with Dr. Samin Saeed, a pharmaceutical medical affairs leader with 17 years of in...
•
Season 2
•
Episode 11
•
28:00
Why Pharma needs Chiefs of Staff with Steve Cirillo-Thompson
In this episode of Pharma Sessions, host Jonathan Kaskey sits down with Steve Cirillo-Thompson, a seasoned Chief of Staff in the pharmaceutical industry, to delve deep into the unique and often misunderstood role of a Chief of Staff. Steve shar...
•
Season 2
•
Episode 10
•
32:41
Achieving Work-Life Integration in Med Affairs with Jen Mohawk
In this episode of Pharma Sessions, host Jonathan Kaskey speaks with Jen Mohawk, Senior Director of Medical Affairs at Apogee Therapeutics. They discuss the pressing issue of burnout, its financial implications, and how companies b...
•
Season 2
•
Episode 9
•
28:09
Future Proofing Medical Affairs with Stephanie Hunter-Banks
Future Proofing Medical Affairs: A Conversation with Stephanie Hunter BanksIn this episode of Pharma Sessions, host Jonathan Kaskey speaks with Stephanie Hunter-Banks about the future of the medical science liaison (MSL) role and the evo...
•
Season 2
•
Episode 8
•
33:47
Kaskey's Hierarchy of Needs for Medical Affairs with guest Stephen Dodge, SVP of Medical Affairs for Madrigal Pharmaceuticals
Kaskey's Hierarchy of Needs in Medical Affairs: Steering towards Successful Product LaunchesThis episode of Pharma Sessions delves into the evolving role of Medical Affairs in pharmaceutical launches, emphasizing its transition from a s...
•
Season 2
•
Episode 7
•
36:01
Using Regulatory Processes to Enhance Patient Care: A Conversation with Lars Dreesmann
In this episode of Pharma Sessions, host Jonathan Kaskey speaks with Lars Dreesmann, the President and Site Head for Boehringer Ingelheim Fremont about how regulatory affairs can impact patient care.They explore the challenges and oppor...
•
Season 2
•
Episode 6
•
36:27
Innovation in Medical Affairs: Embracing AI for Success with Scott Thompson
This episode is sponsored by Acceleration Point. Pharma Sessions is hosted by Jonathan KaskeyIn this episode Jonathan and Scott Thompson, the Co-CEO of Acceleration Point, discuss the impact of Artificial Intelligence (AI) on...
•
Season 2
•
Episode 5
•
30:49
Small Team, Big Impact: Life as The First MSL in a Biotech Startup with Orlando Granado-Balaez
Life is different at a biotech. But is that a good thing?Like so much in life, the answer is, "it depends."On this episode I speak with Orlando Granado-Balaez about his journey from being a nurse to transitioning into medical af...
•
Season 2
•
Episode 4
•
28:13
The Science of Sleep: Exploring its Role in Performance and Well-being for Medical Affairs
The Science of Sleep: Exploring its Role in Performance and Well-being for Medical AffairsIn this episode of Pharma Sessions, Jonathan Kaskey is joined by Dr. Alison Kole, a sleep expert, to discuss the importance of sleep and it...
•
Season 2
•
Episode 3
•
45:21
Global Launch Excellence: Navigating Local and Global Challenges in Pharma with Jose Borbolla-Escoboza
In this compelling episode of Pharma Sessions, host Jonathan Kaskey engages in an insightful discussion with esteemed guest Jose Borbolla-Escoboza. Delving into the intricacies of global launch excellence, Jose, a seasoned oncologist, shares hi...
•
Season 2
•
Episode 2
•
27:27
The Art and Science of Negotiation in Medical Affairs
In this episode of "Pharma Sessions," host Jonathan Kaskey delves into the crucial topic of why negotiation skills are essential in the field of medical affairs. Joining him, Megan Vignos, Head of Scientific and Value Communication...
•
Season 2
•
Episode 1
•
30:13
Gene Therapy Breakthroughs: Exploring the Crucial Role of Medical Affairs with Dr. Huma Qamar
In this episode of Pharma Sessions, host Jonathan Kaskey interviews Dr. Huma Qamar, Head of Clinical Development and Medical Affairs at Ocugen, Inc.With her extensive background in clinical research and medicine, Dr. Qamar has been a pi...
•
Season 2
•
Episode 1
•
32:58
Unlocking Potential: Hidden Data and Disparities in Clinical Trial Participation
Join host Jonathan Kaskey in this thought-provoking episode of Pharma Sessions as he invites special guest Denise Bronner, Director of Clinical Trial Diversity and Inclusion at Janssen, to delve into critical issues facing the pharmaceutical in...
•
Season 1
•
Episode 14
•
33:56
4 Medical Affairs Hacks for Time Management
In this episode, host Jonathan Kaskey invites Patrina Pellet to discuss effective time management strategies for medical professionals. From calendar audits to time blocking, Pellet shares valuable insights on how to optimize your ...
•
Season 1
•
Episode 13
•
32:33
The 4 R's of Medical Information with Tim Fish
We are excited to bring you the latest episode of our podcast series where we tackled the vital role of medical information in the healthcare industry.Tim Fish is the Sr. Director of Medical Information, Knowledge Management, Med/Promo ...
•
Season 1
•
Episode 12
•
23:24
Improving Diversity in Clinical Trials: Challenges and Solutions
This episode is the second in Pharma Sessions' series of conversations about clinical trial diversity. The first episode was with a former pharma executive turned clinical trial consultant. In this episode we share a different, more community o...
•
Season 1
•
Episode 11
•
20:34
Preparing Field Medical for Launch: Challenges and Strategies for Pharma Companies
In Today’s episode Tom Caravela and I explore the question–what does a perfect MSL organization to support a product launch look like?I’ve knonw Tom for years, and asked him to share his unique perspective on field medical organizations....
•
Season 1
•
Episode 10
•
34:22
Navigating the Evolving Landscape of Medical Affairs with Steve Royle
Steve Royle is an innovative pharmaceutical professional with experience in both the commercial and medical affairs sides of the industry. After starting in sales and marketing, Steve moved to the agency side of global medical communicati...
•
Season 1
•
Episode 7
•
31:40
Increasing Clinical Trial Diversity with Camille Pope, Chief Medical Lead at Acclinate
Camille Pope is the Chief Medical Lead at Acclinate, helping pharmaceutical companies and healthcare organizations access and engage communities of color so research is more inclusive.She'd previously worked for several large pharmaceut...
•
32:10
Why Medical Affairs Needs To Care About LinkedIn
Chris Caudle is a LinkedIn specialist for execs working in the healthcare and life sciences sectors. He helps clients to develop their personal brand, increase their visibility, leadership and reach bigger audiences using LinkedIn as their laun...
•
Season 1
•
Episode 7
•
27:23
Standing in Success with Evan Reddick, AVP and Head of Global Medical Affairs Strategy at Menarini Stemline
Evan Reddick recently joined an exciting emerging biotech with a major phase 3 trial win, and preparing to launch a first-in-class oral medication for breast cancer, serving as the AVP and Head of Global Medical Affairs Strategy. Ev...
•
25:40
HEOR with Riad Dirani, Vice President, Global Health Economics and Outcomes Research at Teva Pharmaceuticals
Riad Dirani is the VP of Global HEOR at Teva Pharmaceuticals. We talk about: Customizing data for a global audienceThe importance of a clear medical storyHow to create an insights gathering process...
•
33:04
Patient Journey with Amber Spierer, VP Patient Affairs at EQRx
Amber Spierer is the VP of Patient Affairs at EQRx, formally head of US Patient Engagement at Novartis.We talk about: Defining the patient journeyWhy understanding this journey is important strategi...
•
Season 1
•
Episode 3
•
23:53
Adoption, Insights and Patient Engagement with Pete Piliero, VP Med Affairs at Melinta Therapeutics
I had a great chat with Pete Piliero, VP of Medical Affairs at Melinta Therapeutics.We talk about: Transitioning from clinical practice to med affairsChanges in how other groups in pharma see med affairs
•
Season 1
•
Episode 2
•
26:49